<DOC>
	<DOCNO>NCT02016703</DOCNO>
	<brief_summary>Purpose study : assess maximum tolerate bolus dose erythritol , deliver clear beverage , compare placebo ( saccharose ) 4-6 year old child .</brief_summary>
	<brief_title>Gastrointestinal Tolerance Erythritol-containing Beverages Young Children</brief_title>
	<detailed_description>The study randomize placebo-controlled , double-blind cross-over trial design determine gastrointestinal ( GI ) responses maximum tolerate dose erythritol young child single oral dose beverage in-between meal . The child divide 4 dose group . In group child , one dose level test child expose single dose level versus placebo . The erythritol dose start 5 gram increase 10 g group child precede dose level find significant GI tolerance effect . The effect faecal parameter gastrointestinal complaint record order determine threshold dose . After find significant difference tolerance erythritol placebo 25 g dose cohort , protocol amendment approve allow investigator study dose 20 g. Test material prepare Cargill , Vilvoorde , Belgium supply bottle contain 250 mL noncarbonated fruit-flavoured ( two flavour : strawberry orange ) clear drink sweeten erythritol four different dose level : 5 , 15 , 20 25 g ( equivalent 2 , 6 , 8 10 % w/v erythritol , respectively ) . Placebo supply identical manner prepared common nutritive carbohydrate ( saccharose maltodextrin ) provide equivalent sweetness correspond erythritol beverage ( i.e . : 1.4 , 4.2 , 5.6 7 % w/v ) . In total 185 healthy young child age 4-6 year recruit three clinical investigation centre inform consent parent ; 184 complete study .</detailed_description>
	<mesh_term>Erythritol</mesh_term>
	<criteria>Healthy Age 4 6 year Study D1 ( day consumption first beverage ) Body Mass Index ³ 13 kg/m² Accustomed breakfast Having regular defecation frequency inferior equal two per day Able drink 250 mL within 15 minute Toilettrained / able use potty ( day night ) Informed consent person entitle parental right Person entitle parental right affiliate French social security Participation clinical trial include blood sample and/or administration substance 90 day D1 study Participation noninvasive clinical trial 30 day D1 study , include blood sampling and/ , intravenous , inhalatory administration substance Having history medical surgical event may significantly affect study outcome , gastric digestive disease Any current metabolic endocrine disease , include diabetes mellitus Use medication , include antibiotic , laxatives steroid Regular gastrointestinal complaint , stomach upset , diarrhoea , constipation , flatulence , abdominal colic</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>erythritol</keyword>
	<keyword>polyol</keyword>
	<keyword>laxation</keyword>
	<keyword>gastrointestinal</keyword>
	<keyword>tolerance</keyword>
	<keyword>soft drink</keyword>
	<keyword>child</keyword>
	<keyword>diarrhoea</keyword>
</DOC>